It is estimated that close to 78 million patients in India are having Diabetes, of these about 12% patients require insulin daily to manage the disease and also there are other therapies wherein self-injection – pen devices require these needles which are used for drug delivery. Elaborating on the need further, Ashit Sikka, Senior Director: TPS -India & China said, “With a growing number of patients requiring sub-Q delivery of medication for diverse medical conditions on a regular basis, the need for self-injection is growing significantly, both in India and globally. It is therefore important that patients/ caregivers are empowered to manage drug administration accurately, yet conveniently. We believe that FineGlide™ provides patients with such a much-needed option.”
FineGlide® is the first product from the Life Care Solutions division of Terumo Medical Care Solutions being launched in India. Designed as a 3-bevel super sharp needle with high-grade silicone surface, Fineglide™ is gentle and more comfortable for patients. It’s built with Thin Wall Technology to ensure greater flow rate and provides better penetration requiring lesser injection force when compared with other alternatives in the market. Compatible with most commonly available pen devices in India, Fineglide® is available in multiple sizes ranging from 4 mm to 12.7 mm length and 29-32 gauge thickness to suit varied applications.
As an offering of Terumo Corporation, FineGlide® brings along a 100-year legacy of trust and care. The needles are available in the Indian market bi-packed with some major pharmaceutical companies along with their products requiring self-administration with pen device. Now, FineGlide® will also be available as a standalone product in all major pharmacies across India. For more details about the product visit: https://www.terumoindiaskilllab.com/products/fineglide.
